Position in CBLL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,995,205
+$1,777,668 QoQ
Shares Held
668,134
+9.2% QoQ
Ownership
1.74%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 123 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CBLL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $16,510,306,841 across 125 Medical Devices names. CBLL ranks #46 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
39,219,337 | $3,558,762,638 | |
| 2 | SYK |
Stryker Corp
|
7,819,802 | $2,461,986,461 | |
| 3 | MDT |
Medtronic plc
|
30,192,015 | $2,361,921,333 | |
| 4 | BSX |
Boston Scientific Corp
|
33,440,102 | $1,427,223,552 | |
| 5 | EW |
Edwards Lifesciences Corp
|
15,437,251 | $1,396,453,724 | |
| 6 | DXCM |
Dexcom Inc
|
12,426,515 | $836,925,784 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
12,871,800 | $823,923,917 | |
| 8 | STE |
STERIS plc
|
2,615,842 | $550,817,849 |
All Filings in CBLL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,995,205 | 668,134 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $11,217,537 | 611,977 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,360,918 | 609,253 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $6,686,420 | 581,934 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $8,389,841 | 447,936 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $5,537,051 | 288,238 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,652,971 | 257,070 | Shares | Defined | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||